Tyra Biosciences (TYRA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $18.52, -2.73% vs the prior close of $19.04.
- Volume 648.94K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TYRA dips 2.7% to $18.52, a 6-month low. Closed at $18.52, -2.73% vs the prior close of $19.04. Day range $18.26–$19.09, opened at $19.03.
TYRA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TYRA dips 2.7% to $18.52, a 6-month low
- Closed at $18.52, -2.73% vs the prior close of $19.04. Day range $18.26–$19.09, opened at $19.03.
- Volume was 648.94K shares, 0.7x its 50-day average of 896.67K.
- Price is -21.8% vs its 50-day average ($23.68) and -38.8% vs its 200-day average ($30.25).
- 52-week range $13.35–$40.65; today's close sits at 19% of that range, 54.4% below the 52-week high.
Oct 15, 2026 — TYRA rises 1.8% to $19.04
- Closed at $19.04, +1.82% vs the prior close of $18.70. Day range $18.76–$19.30, opened at $18.86.
- Volume was 418.00K shares, 0.4x its 50-day average of 943.15K — lighter than usual.
- Price is -20.2% vs its 50-day average ($23.85) and -37.1% vs its 200-day average ($30.28).
- 52-week range $13.35–$40.65; today's close sits at 21% of that range, 53.2% below the 52-week high.
Oct 14, 2026 — TYRA rises 0.8% to $18.70
- Closed at $18.70, +0.75% vs the prior close of $18.56. Day range $18.25–$18.83, opened at $18.44.
- Volume was 484.00K shares, 0.5x its 50-day average of 941.40K — lighter than usual.
- Price is -22.0% vs its 50-day average ($23.98) and -38.3% vs its 200-day average ($30.31).
- 52-week range $13.35–$40.65; today's close sits at 20% of that range, 54.0% below the 52-week high.
Oct 13, 2026 — TYRA slides 5.3% to $18.56, a 6-month low, 4 down days in a row
- Closed at $18.56, -5.31% vs the prior close of $19.60. Day range $18.53–$19.60, opened at $19.39.
- Volume was 469.50K shares, 0.5x its 50-day average of 942.15K — lighter than usual.
- Price is -23.5% vs its 50-day average ($24.26) and -38.8% vs its 200-day average ($30.35).
- 52-week range $13.35–$40.65; today's close sits at 19% of that range, 54.3% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — TYRA dips 1.7% to $19.60, a 6-month low, 3 down days in a row
- Closed at $19.60, -1.71% vs the prior close of $19.94. Day range $19.51–$20.03, opened at $19.73.
- Volume was 334.40K shares, 0.4x its 50-day average of 949.72K — lighter than usual.
- Price is -20.1% vs its 50-day average ($24.53) and -35.5% vs its 200-day average ($30.39).
- 52-week range $13.29–$40.65; today's close sits at 23% of that range, 51.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — TYRA ends flat (-0.2%) to $19.94, a 6-month low
- Closed at $19.94, -0.15% vs the prior close of $19.97. Day range $19.73–$20.59, opened at $19.93.
- Volume was 649.40K shares, 0.7x its 50-day average of 953.81K.
- Price is -19.5% vs its 50-day average ($24.77) and -34.4% vs its 200-day average ($30.42).
- 52-week range $13.29–$40.65; today's close sits at 24% of that range, 50.9% below the 52-week high.
Oct 8, 2026 — TYRA dips 2.1% to $19.97, a 6-month low
- Closed at $19.97, -2.06% vs the prior close of $20.39. Day range $19.50–$20.17, opened at $20.12.
- Volume was 792.30K shares, 0.8x its 50-day average of 947.89K.
- Price is -20.2% vs its 50-day average ($25.04) and -34.4% vs its 200-day average ($30.44).
- 52-week range $13.29–$40.65; today's close sits at 24% of that range, 50.9% below the 52-week high.
Oct 7, 2026 — TYRA rises 0.7% to $20.39
- Closed at $20.39, +0.74% vs the prior close of $20.24. Day range $19.80–$20.79, opened at $19.97.
- Volume was 477.70K shares, 0.5x its 50-day average of 946.54K — lighter than usual.
- Price is -19.3% vs its 50-day average ($25.26) and -33.1% vs its 200-day average ($30.47).
- 52-week range $13.17–$40.65; today's close sits at 26% of that range, 49.8% below the 52-week high.
Oct 6, 2026 — TYRA slides 3.3% to $20.24, a 6-month low
- Closed at $20.24, -3.30% vs the prior close of $20.93. Day range $19.60–$20.99, opened at $20.93.
- Volume was 763.40K shares, 0.8x its 50-day average of 940.74K.
- Price is -20.5% vs its 50-day average ($25.47) and -33.6% vs its 200-day average ($30.49).
- 52-week range $12.98–$40.65; today's close sits at 26% of that range, 50.2% below the 52-week high.
Oct 5, 2026 — TYRA rises 2.4% to $20.93
- Closed at $20.93, +2.45% vs the prior close of $20.43. Day range $19.94–$21.03, opened at $20.57.
- Volume was 614.40K shares, 0.7x its 50-day average of 941.38K.
- Price is -18.5% vs its 50-day average ($25.68) and -31.4% vs its 200-day average ($30.50).
- 52-week range $12.98–$40.65; today's close sits at 29% of that range, 48.5% below the 52-week high.
Oct 2, 2026 — TYRA dips 2.8% to $20.43, a 6-month low, 3 down days in a row
- Closed at $20.43, -2.76% vs the prior close of $21.01. Day range $20.17–$21.39, opened at $21.25.
- Volume was 1.05M shares, 1.1x its 50-day average of 929.14K.
- Price is -21.1% vs its 50-day average ($25.88) and -33.0% vs its 200-day average ($30.51).
- 52-week range $12.98–$40.65; today's close sits at 27% of that range, 49.7% below the 52-week high.
- That makes 3 straight losses.
TYRA latest news & SEC filings
Every SEC filing by or about TYRA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 21, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Harris Todd received an award of 864 shares at $9.13 (≈$7.89K) on Sep 15, 2026; now holds 1,438,495
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rueb Yuliya received an award of 2,925 shares at $9.13 (≈$26.70K) on Sep 15, 2026; now holds 11,258
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Fuhrman Alan received an award of 951 shares at $9.13 (≈$8.68K) on Sep 15, 2026; now holds 37,115
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 17, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 15, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 14, 2026 · Form FWP — Free writing prospectus (offering marketing material)
Free writing prospectus (offering marketing material)
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 14, 2026 · Form S-3ASR — S-3ASR filing
S-3ASR filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Verjee Rehan bought 972 shares at $20.58 (≈$20.00K) on Sep 9, 2026
- Verjee Rehan bought 972 shares at $20.58 (≈$20.00K) on Sep 9, 2026
- Verjee Rehan bought 972 shares at $20.58 (≈$20.00K) on Sep 9, 2026
- Verjee Rehan bought 972 shares at $20.58 (≈$20.00K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade TYRA
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 2, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.42% (largest 9.2%).
- Liquidity: about 788.43K shares (≈$14.60M) trade per day on average.
- 52-week position: $18.52 vs a range of $13.35–$40.65 (19% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 21 sales; latest: Rehan Verjee bought 972 shares on Sep 9, 2026.
- Latest filings: 8-K Sep 15, 2026; 8-K Sep 9, 2026; 10-Q Aug 4, 2026.
- Share count: 59.68M shares outstanding (Jul 31, 2026), +12.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
TYRA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 19.03 | 19.09 | 18.26 | 18.52 | 648.94K |
| Oct 15, 2026 | 18.86 | 19.30 | 18.76 | 19.04 | 418.00K |
| Oct 14, 2026 | 18.44 | 18.83 | 18.25 | 18.70 | 484.00K |
| Oct 13, 2026 | 19.39 | 19.60 | 18.53 | 18.56 | 469.50K |
| Oct 12, 2026 | 19.73 | 20.03 | 19.51 | 19.60 | 334.40K |
| Oct 9, 2026 | 19.93 | 20.59 | 19.73 | 19.94 | 649.40K |
| Oct 8, 2026 | 20.12 | 20.17 | 19.50 | 19.97 | 792.30K |
| Oct 7, 2026 | 19.97 | 20.79 | 19.80 | 20.39 | 477.70K |
| Oct 6, 2026 | 20.93 | 20.99 | 19.60 | 20.24 | 763.40K |
| Oct 5, 2026 | 20.57 | 21.03 | 19.94 | 20.93 | 614.40K |
| Oct 2, 2026 | 21.25 | 21.39 | 20.17 | 20.43 | 1.05M |
| Oct 1, 2026 | 21.78 | 22.32 | 20.88 | 21.01 | 889.70K |
| Sep 30, 2026 | 22.19 | 22.45 | 21.70 | 21.87 | 1.03M |
| Sep 29, 2026 | 21.37 | 22.62 | 21.28 | 21.98 | 500.00K |
| Sep 28, 2026 | 21.57 | 21.92 | 21.00 | 21.45 | 824.60K |
| Sep 25, 2026 | 22.33 | 22.41 | 21.67 | 21.76 | 1.42M |
| Sep 24, 2026 | 23.17 | 23.41 | 22.12 | 22.41 | 1.09M |
| Sep 23, 2026 | 25.27 | 25.39 | 22.86 | 23.23 | 1.10M |
| Sep 22, 2026 | 25.77 | 26.43 | 25.20 | 25.57 | 1.22M |
| Sep 21, 2026 | 26.04 | 26.96 | 25.40 | 25.65 | 989.20K |
About Tyra Biosciences
Tyra Biosciences (TYRA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CARLSBAD, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1863127.
TYRA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Habib J Dable | Director | Apr 20, 2026 |
| Adele M. Gulfo | Director | Jun 1, 2026 |
| Todd Harris | President and CEO | Sep 17, 2026 |
| Gilla Kaplan | Director | Mar 27, 2026 |
| Peter Kolchinsky | Director | Sep 17, 2026 |
| Robert J More | Director | Jun 1, 2026 |
| Susan Moran | Director | Jun 1, 2026 |
| Capital Management, L.P. Ra | Director | Sep 17, 2026 |
| Capital Healthcare Fund Lp Ra | Director | Sep 17, 2026 |
| Capital Nexus Fund, L.P. Ra | Director | Sep 17, 2026 |
| Stephen Michael Rothenberg | Director | Jun 1, 2026 |
| Rajeev M. Shah | Director | Sep 17, 2026 |
| Jake Simson | Director | Jun 1, 2026 |
| Rehan Verjee | Director | Sep 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bhavesh Ashar | Chief Operating Officer | May 7, 2026 |
| Daniel Bensen | Chief Discovery Officer | Feb 13, 2026 |
| Alan Fuhrman | Chief Financial Officer | Sep 17, 2026 |
| Todd Harris | President and CEO | Sep 17, 2026 |
| Yuliya Rueb | Vice President, Finance (PAO) | Sep 17, 2026 |
| Douglas J Warner | Chief Medical Officer | May 7, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 9, 2026 | Rehan Verjee | Buy | 972 | $20.58 |
| Sep 9, 2026 | Rehan Verjee | Buy | 972 | $20.58 |
| Sep 9, 2026 | Rehan Verjee | Buy | 972 | $20.58 |
| Sep 9, 2026 | Rehan Verjee | Buy | 972 | $20.58 |
| Mar 25, 2026 | Gilla Kaplan | Sale | 14,295 | $36.97 |
| Mar 25, 2026 | Gilla Kaplan | Sale | 14,295 | $36.97 |
| Mar 25, 2026 | Gilla Kaplan | Sale | 14,295 | $36.97 |
| Mar 25, 2026 | Gilla Kaplan | Sale | 14,295 | $36.97 |
| Feb 12, 2026 | Daniel Bensen | Sale | 2,128 | $31.50 |
| Feb 12, 2026 | Daniel Bensen | Sale | 5,872 | $33.37 |
| Feb 12, 2026 | Daniel Bensen | Sale | 2,128 | $31.50 |
| Feb 12, 2026 | Daniel Bensen | Sale | 5,872 | $33.37 |
| Feb 12, 2026 | Daniel Bensen | Sale | 2,128 | $31.50 |
| Feb 12, 2026 | Daniel Bensen | Sale | 5,872 | $33.37 |
| Feb 12, 2026 | Daniel Bensen | Sale | 2,128 | $31.50 |
TYRA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-119.95M | -2.01 | $-95.14M |
| Dec 31, 2024 | — | $-86.48M | -1.51 | $-69.77M |
| Dec 31, 2023 | — | $-69.13M | -1.62 | $-50.14M |
| Dec 31, 2022 | — | $-55.33M | -1.32 | $-50.28M |
| Dec 31, 2021 | — | $-26.29M | -1.91 | $-23.75M |
Latest balance sheet: total assets $383.36M, total liabilities $29.70M, cash $73.83M (as of Jun 30, 2026).
TYRA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $32.53 |
| May 13, 2026 | 8-K Item 2.02 (results) | $36.19 |
| Mar 2, 2026 | 8-K Item 2.02 (results) | $32.52 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $14.82 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $10.70 |
| May 8, 2025 | 8-K Item 2.02 (results) | $10.07 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $9.66 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $17.15 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 19, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TYRA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.